Intracranial Complications From Immune Checkpoint Therapy in a Patient With NSCLC and Multiple Sclerosis: Case Report
Background: Immune checkpoint inhibitors (ICIs) have become an increasingly important tool in cancer treatment, revealing durable responses in several Armored Vehicle different types of tumors, including NSCLCs.Nevertheless, ICIs carry a risk of immune-mediated toxicities.There is a paucity of data for concurrent use of these agents in patients wit